JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
最新資料
¥452
+¥6.00 · +1.35%
盤中時間採用JST。市場資料可能有所延遲。
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
日內區間
目前¥452
52週區間
目前¥452
盤中時間採用JST。市場資料可能有所延遲。
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
日內區間
目前¥452
52週區間
目前¥452
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(JPY) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 658.45億 JPY | 697.49億 JPY | 652.92億 JPY | 637.4億 JPY | 581.69億 JPY |
| 銷貨成本 | 504.89億 JPY | 538.24億 JPY | 511.98億 JPY | 491.45億 JPY | 438.99億 JPY |
| 毛利 | 153.56億 JPY | 159.25億 JPY | 140.94億 JPY | 145.95億 JPY | 142.7億 JPY |
| 研究與開發 | — | — | 15.18億 JPY | 13.18億 JPY | 15.31億 JPY |
| 銷售、一般及管理費用 | 149.73億 JPY | 150.51億 JPY | 124.45億 JPY | 121.23億 JPY | 113.73億 JPY |
| 營業費用 | 149.73億 JPY | 150.51億 JPY | 143.62億 JPY | 138.69億 JPY | 132.88億 JPY |
| 利息收入 | 3100萬 JPY | 1900萬 JPY | 1400萬 JPY | 1200萬 JPY | 700萬 JPY |
| 利息支出 | 4.07億 JPY | 3.4億 JPY | 2.2億 JPY | 1.67億 JPY | 1.59億 JPY |
| 折舊和攤銷 | 38.33億 JPY | 38.88億 JPY | 37.14億 JPY | 35.93億 JPY | 33.59億 JPY |
| 營業利益 | 3.83億 JPY | 8.74億 JPY | −2.68億 JPY | 7.24億 JPY | 9.8億 JPY |
| 淨利 | −7.84億 JPY | 8900萬 JPY | −3600萬 JPY | 2.81億 JPY | 8.26億 JPY |
公司資料更新於 2026年10月6日。
近期已公布業績
近期已公布業績
年度分割調整後的每股現金分配。
¥17.00
2025年(完整年度)0.0% 自從 2021
2026年(部分年度):¥17.00
¥17.00
2,021
¥17.00
2,022
¥17.00
2,023
¥17.00
2,024
¥17.00
2,025
¥17.00
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息即將實施 | 2027年3月30日 | ¥8.50Semi-Annual | 2027年3月31日 | 2027年3月30日 |
股息 | 2026年9月29日 | ¥8.50Semi-Annual | 2026年9月30日 | 2026年9月29日 |
股息 | 2026年3月30日 | ¥8.50Semi-Annual | 2026年3月31日 | 2026年6月24日 |
股息 | 2025年9月29日 | ¥8.50Semi-Annual | 2025年9月30日 | 2025年12月10日 |
股息 | 2025年3月28日 | ¥8.50Semi-Annual | 2025年3月31日 | 2025年6月25日 |
股息 | 2024年9月27日 | ¥8.50Semi-Annual | 2024年9月30日 | 2024年12月10日 |
除息 2027年3月30日
¥8.50
Semi-Annual
2027年3月31日登記 · 支付日 2027年3月30日
除息 2026年9月29日
¥8.50
Semi-Annual
2026年9月30日登記 · 支付日 2026年9月29日
除息 2026年3月30日
¥8.50
Semi-Annual
2026年3月31日登記 · 支付日 2026年6月24日
除息 2025年9月29日
¥8.50
Semi-Annual
2025年9月30日登記 · 支付日 2025年12月10日
除息 2025年3月28日
¥8.50
Semi-Annual
2025年3月31日登記 · 支付日 2025年6月25日
除息 2024年9月27日
¥8.50
Semi-Annual
2024年9月30日登記 · 支付日 2024年12月10日
報告持有此股票曝險的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T2.54億0.00%35.51兆 JPY0.05%¥440.4+0.94%
iShares Core TOPIX ETF1475.T2419.2萬0.00%3.04兆 JPY0.05%¥433.8+1.12%
Dimensional - International Small Cap Value ETFDISV5.34萬0.00%50.95億 USD0.42%US$42.97+0.14%
Dimensional - International Core Equity 2 ETFDFIC4.95萬0.00%150.9億 USD0.22%US$37.71+0.11%
Dimensional World ex U.S. Core Equity 2 ETFDFAX2.88萬0.00%124.35億 USD0.28%US$37.45+0.46%
Dimensional - International Small Cap ETFDFIS9035.20.00%57.51億 USD0.39%US$36.16-0.11%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
iShares Core TOPIX ETF1475.T
Dimensional - International Small Cap Value ETFDISV
Dimensional - International Core Equity 2 ETFDFIC
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Dimensional - International Small Cap ETFDFISAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。